Dr. Richard Furman Discusses Emerging Strategies for the Treatment of CLL & Follicular Lymphoma

In this video from Onc Live, Dr. Richard Furman, Director of the CLL Research Center discusses emerging strategies in the treatment of CLL and follicular lymphoma, specifically citing the use of venetoclax also known as ABT-199.

For patients with CLL the following trials are open to accrual.

Dr. John Leonard Discusses Ibrutinib Combined with Chemotherapy for Patients with Follicular Lymphoma

In this video clip from OncLive Lymphoma Program Director, John Leonard, MD discusses the phase III SELENE study, which examined the addition of ibrutinib to either R-CHOP or bendamustine plus rituximab for the treatment of patients with follicular lymphoma.

Other trials for follicular lymphoma can be found on our clinical trials listings.

REDLAMP 9: Prognostic Factors for Clinical Outcomes in Patients with Plasmablastic Lymphoma

Plasmablastic lymphoma is an aggressive diffuse large B-cell lymphoma commonly associated with HIV infection, and an unfavorable diagnosis. Though it’s also often found in immunocompetent patients. The Journal of Hematology & Oncology recently published a clinicopathologic analysis of patients with plasmablastic lymphoma, and measured their outcomes. In this video, Dr. John Allan explains the results of this study, and offers takeaways for patients with this aggressive lymphoma.

Previous #REDLAMP entries can be viewed on our Youtube channel.

We encourage you to follow the Lymphoma Program on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 212-746-2919.